Navigation Links
Ranbaxy and Pfizer Settle Lipitor Litigation Worldwide
Date:6/18/2008

Ranbaxy Will Market Generic Atorvastatin in the U.S. With 180 Days

Exclusivity From Nov. 30, 2011

Agreement Also Resolves Caduet, Accupril Litigation in the US

GURGAON, Harayana, India and PRINCETON, N.J., June 18 /PRNewswire/ -- Ranbaxy Laboratories Limited (Ranbaxy), announced today that it has entered into an agreement with Pfizer Inc. to settle most of the patent litigation worldwide involving Atorvastatin (Lipitor), the world's most-prescribed cholesterol-lowering medicine. This decision will allow for an earlier introduction of a generic formulation that will benefit patients and many healthcare systems throughout the world. Lipitor is the world's largest selling drug with worldwide sales in 2007 of $12.7 billion.

The agreement pertains solely to Ranbaxy and its affiliates and does not cover legal challenges to the Lipitor patents involving other generic manufacturers. However, as Ranbaxy was the first generic challenger to the listed Lipitor patents, it retains the right to the marketing exclusivity of 180 days in the United States. Under the terms of the agreement, Ranbaxy will have a license to sell generic versions of Atorvastatin and the fixed-dose combination of Atorvastatin-Amlodipine besylate in the United States effective Nov. 30, 2011.

Welcoming the development, Malvinder Mohan Singh, CEO and MD, Ranbaxy Laboratories Ltd., said, "This comprehensively settles outstanding issues between Ranbaxy and Pfizer bringing to closure a number of ongoing patent disputes. It also provides certainty and visibility to the launch of Ranbaxy's Generic Atorvastatin, with 180-day market exclusivity in the US and an early entry in other markets. This will make the worlds largest selling drug more accessible to patients who will gain from the timely availability of an affordable quality option."

Ranbaxy will also have a license to sell Atorvastatin on varying dates in an additional 7 countries, includi
'/>"/>

SOURCE Ranbaxy Laboratories Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Ranbaxy to Bring in Daiichi Sankyo as Majority Partner; Strategic Combination Creates Innovator and Generic Pharma Powerhouse
2. Ranbaxy Receives Final Approval to Manufacture and Market Cetirizine Hydrochloride Oral Solution
3. Ranbaxy Gains Approval to Manufacture and Market Cefuroxime Axetil for Oral Suspension
4. Ranbaxy Receives Final Approval to Manufacture and Market Cetirizine Hydrochloride Tablets (OTC), 5mg and 10mg
5. Ranbaxy Receives Tentative Approval For Valsartan Tablets
6. Ranbaxy First to Gain Approval to Manufacture and Market Clarithromycin for Oral Suspension, USP
7. Ranbaxy Gains Approval to Manufacture and Market Carvedilol Tablets in the U.S. Market
8. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
9. Novartis, Pfizer and Merck Take the Lead on Strong Relationships with Physicians, as Doctors Demand an Expanding Set of Services
10. Pfizers work on penicillin for World War II becomes a National Historic Chemical Landmark
11. AUDIO from Medialink and Pfizer: Free Programs for Uninsured Men and Women Who Need Help Paying for Medicine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/19/2014)... U.S. Government has initiated a major effort to ... However, a workgroup of nearly 40 Alzheimer,s researchers ... U.S. Government,s National Plan to Address Alzheimer,s Disease ... and adequately funded in order to successfully achieve ... workgroup to enlarge and strengthen the Plan are ...
(Date:10/19/2014)... October 19, 2014 When patients and their ... Hospital and turn the corner to face the Hummingbird Gift ... hospital volunteers to sell there. There’s unique home décor. Cooking ... so obvious, though, is the importance this small gift shop ... Tappahannock and Northern Neck community of the future. , ...
(Date:10/18/2014)... NY (PRWEB) October 19, 2014 Bon ... specializing in long-term and rehabilitation care in the Riverdale ... G. Beato, chief executive officer, was honored by New ... the CHA Corporate Alumni award at their 30th Annual ... degree in healthcare administration from New Jersey City University ...
(Date:10/18/2014)... 2014 Asbestos Likely More Widespread Than ... more widespread than previously thought, with newly discovered sources ... asbestos-rich areas are in locations not previously considered to ... be presented at the Annual Meeting of the Geological ... 20 October. , “These minerals were found where one ...
(Date:10/18/2014)... October 18, 2014 Ticket Down is a reputable ... eased considerably for this year's World Series. , The ... World Series this year. This determined team has not made ... Francisco Giants have had better luck in terms of participating in ... 1933, 1922, 1921 and 1905. This team had a ...
Breaking Medicine News(10 mins):Health News:Scientists say national Alzheimer's plan milestones must be strengthened to meet goal by 2025 2Health News:Scientists say national Alzheimer's plan milestones must be strengthened to meet goal by 2025 3Health News:Scientists say national Alzheimer's plan milestones must be strengthened to meet goal by 2025 4Health News:Scientists say national Alzheimer's plan milestones must be strengthened to meet goal by 2025 5Health News:Scientists say national Alzheimer's plan milestones must be strengthened to meet goal by 2025 6Health News:Riverside Tappahannock Hospital Capital Campaign Gets Boost From Community Through Gift Shop 2Health News:Riverside Tappahannock Hospital Capital Campaign Gets Boost From Community Through Gift Shop 3Health News:Carlos G. Beato Honored by New Jersey City University’s Council on Hispanic Affairs (CHA) 2Health News:Carlos G. Beato Honored by New Jersey City University’s Council on Hispanic Affairs (CHA) 3Health News:Asbestos Likely More Widespread Than Previously Thought 2Health News:Asbestos Likely More Widespread Than Previously Thought 3Health News:2014 World Series Tickets: Giants vs. Royals World Series Ticket Prices Have Eased Substantially 2
... S.C. accident could help other communities take necessary steps , , ... in 2005, a freight train with three tanker cars -- ... a parked locomotive in the center of Graniteville, S.C., a ... , One tank ruptured during the 2 a.m. collision, releasing ...
... The Healthcare Communication &,Marketing Association (HCMA) today ... will take place at the new Westin Hotel ... the first time, the event will focus on ... Leaders from,medical device, pharmaceutical, biotechnology, diagnostics and ...
... (Nasdaq: GHDX ) today announced the appointment ... president and chief operating officer,Popovits is now the president ... Cole has been appointed as chief operating officer and ... reporting to Popovits. , "Kim,s ...
... 8 Bill Germanakos, the 4th-season winner in the ... will be the special guest at two weight management ... Mansfield Medical Centers. The workshops, hosted by Methodist Weight ... people who want to make a healthy change through ...
... Organ Donors and Provide the Gift of LifeNEW YORK, ... pop band 98 Degrees, kicked off 2009 with a ... sign up today to become organ donors offering the ... the celebrity spokesperson for the newly formed Heather Trew ...
... Professionals are asked to do more with less than ever before. But ... to do? Learn how to put together a rock solid business case ... technology can pay for itself (and then some) in the first year. ... ...
Cached Medicine News:Health News:Preparing for a Chlorine Gas Disaster 2Health News:Preparing for a Chlorine Gas Disaster 3Health News:The Healthcare Communication & Marketing Association Announces June 2009 Conference and IN-AWE and Delta Awards Ceremony 2Health News:Genomic Health Announces Management Changes and New Responsibilities 2Health News:Genomic Health Announces Management Changes and New Responsibilities 3Health News:Genomic Health Announces Management Changes and New Responsibilities 4Health News:Methodist Weight Management Institute Brings NBC's 'Biggest Loser' to Dallas and Mansfield 2Health News:Methodist Weight Management Institute Brings NBC's 'Biggest Loser' to Dallas and Mansfield 3Health News:Jeff Timmons and the Heather Trew Foundation Join Forces to Promote Organ Donations 2Health News:Now, More Than Ever, Automating Compensation Planning Is A Good Financial Decision 2Health News:Now, More Than Ever, Automating Compensation Planning Is A Good Financial Decision 3
(Date:10/16/2014)... -- Eight finalists, all representing outstanding innovation in pediatric ... for a chance to compete for one of two ... Second Annual Pediatric Surgical Innovation Symposium hosted by ... 24, 2014. Selected from a competitive field ... internationally, the finalists are: , Creative ...
(Date:10/16/2014)... , Oct. 16, 2014   NuVascular ... process to create new medical devices that help ... Inc., the company uses cutting-edge nanotechnology that would ... kidney diseases.  The platform technology ... result of $6.6 million in funding obtained from ...
(Date:10/16/2014)... 2014 Ninety percent of children and adults ... times or failed to respond to standard therapies went ... CTL019, developed at the Perelman School of Medicine at ... The New England Journal of Medicine ... preliminary findings presented at the American Society of Hematology,s ...
Breaking Medicine Technology:Finalists for Children's National Health System pediatric medical device competition announced 2Finalists for Children's National Health System pediatric medical device competition announced 3Finalists for Children's National Health System pediatric medical device competition announced 4Nanotechnology Venture Targets Arterial, Heart and Kidney Diseases 2Nanotechnology Venture Targets Arterial, Heart and Kidney Diseases 3Personalized Cellular Therapy Achieves Complete Remission in 90 Percent of Acute Lymphoblastic Leukemia Patients Studied 2Personalized Cellular Therapy Achieves Complete Remission in 90 Percent of Acute Lymphoblastic Leukemia Patients Studied 3Personalized Cellular Therapy Achieves Complete Remission in 90 Percent of Acute Lymphoblastic Leukemia Patients Studied 4Personalized Cellular Therapy Achieves Complete Remission in 90 Percent of Acute Lymphoblastic Leukemia Patients Studied 5Personalized Cellular Therapy Achieves Complete Remission in 90 Percent of Acute Lymphoblastic Leukemia Patients Studied 6
... Inc. (Nasdaq: BNVI ), a pharmaceutical company focused ... for women,s health and cancer, today announced the pricing of ... 30,031,200 units at a price per unit of $1.00 for ... of one share of common stock and a warrant to ...
... Information Systems ("SIS"), a leader in perioperative ... successfully completed the healthcare industry,s week-long interoperability ... Connectathon. (Logo: http://photos.prnewswire.com/prnh/20080722/SISLOGO) ... industry,s largest interoperability testing event designed to ...
Cached Medicine Technology:Bionovo Announces Pricing of Follow-on Offering of Common Stock and Warrants 2Bionovo Announces Pricing of Follow-on Offering of Common Stock and Warrants 3Surgical Information Systems Completes IHE North American Connectathon 2
The Soft-Touch Timeter® Flowmeter is durable, long-lasting and easy to maintain. Timeter ® by Allied Flowmeters: Quality Plus Value....
The Soft-Touch Timeter® Flowmeter is durable, long-lasting and easy to maintain. Timeter ® by Allied Flowmeters: Quality Plus Value....
... line of flowmeters, available in oxygen, ... They are all available in a ... your application. With color coded labels ... in use, the Amvex Flowmeter is ...
... Amvex offers a complete line ... heliox and CO 2 . They ... of calibrations to best suit your ... dials specific to the gas in ...
Medicine Products: